Myelodysplastic Syndromes (MDS)

Risk prediction for clonal cytopenia: multicenter real-world evidence

Original Publication Date
Article Source
External Web Content
Key Points A 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia. The CCRS offers precise CCUS risk assessment for patient management and clinical trial eligibility. Abstract Clonal cytopenia of undetermined significance (CCUS) represents…

Trent Peng Wang, DO

Institution
University of Miami Health System - Sylvester Comprehensive Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pure Red Cell Aplasia (PRCA)
About
Dr. Trent Wang is an Associate Professor of Clinical Medicine within the Division of Transplantation and Cellular Therapy. Since joining Sylvester Comprehensive Cancer Center, his clinical focus has been treating patients with hematologic cancers who require allogeneic hematopoietic stem cell transplantation and other cellular therapies. Dr. Wang's research focuses on complications of allogeneic hematopoietic stem cell transplantation, including conducting interventional, behavioral and retrospective studies of graft-versus-host disease, infectious transplant complications, and transplant
Subscribe to Myelodysplastic Syndromes (MDS)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.